Business Segments

9 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Business Segments

9. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by geographic region, based on the sales destination, is as follows:

	Three Months Ended				Nine Months Ended
	September 30, 2017		October 1, 2016		September 30, 2017		October 1, 2016
United States	$	6,294	$	5,871	$	17,880	$	18,642
Europe		1,727		2,191		5,502		6,779
Rest of Americas		689		476		1,853		1,858
Asia/Pacific Rim		2,155		1,251		6,115		6,349
	$	10,865	$	9,789	$	31,350	$	33,628

Revenues are attributed to countries based on location of end customers. No individual country accounted for more than 10% of the Company’s revenues, other than the United States. United States accounted for 57.9% and 60.0% of revenues for the three month periods ended September 30, 2017 and October 1, 2016, respectively. For the nine month period ended September 30, 2017 and October 1, 2016, the United States accounted for 57.0% and 55.4% of sales, respectively. International sales, other than the United States, accounted for 42.1% and 40.0% of revenues for the three month periods ended September 30, 2017 and October 1, 2016, respectively. For nine month period ended September 30, 2017 and October 1, 2016, International sales, other than the United States, accounted for 43.0% and 44.6% of sales, respectively.